NASDAQ: PTIX
Protagenic Therapeutics Inc Stock Ownership - Who owns Protagenic Therapeutics?

Insider buying vs selling

Have Protagenic Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PTIX insiders and whales buy or sell their stock.

PTIX Shareholders

What type of owners hold Protagenic Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hrt Financial LP21.06%124,015$458.86kInstitution
Geode Capital Management LLC13.12%77,296$286.00kInstitution
Virtu Financial LLC9.43%55,530$205.46kInstitution
Alexander K. Arrow7.78%45,815$169.52kInsider
Vanguard Group Inc5.63%33,166$122.71kInstitution
Two Sigma Securities LLC4.75%27,968$103.48kInstitution
State Street Corp2.35%13,812$51.10kInstitution
Tower Research Capital LLC Trc1.00%5,917$21.89kInstitution
Bank Of America Corp0.01%54$199.80Institution
Cwm LLC0.00%1$3.70Institution

1 of 2

PTIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTIX57.35%7.78%
ALZN0.18%99.82%Net BuyingNet Selling
SLRX0.55%99.45%
CDT0.82%99.18%Net SellingNet Buying
PCSA1.44%34.14%Net BuyingNet Selling

Protagenic Therapeutics Stock Ownership FAQ

Who owns Protagenic Therapeutics?

Protagenic Therapeutics (NASDAQ: PTIX) is owned by 57.35% institutional shareholders, 7.78% Protagenic Therapeutics insiders, and 34.87% retail investors. Alexander K. Arrow is the largest individual Protagenic Therapeutics shareholder, owning 45,815.00 shares representing 7.78% of the company. Alexander K. Arrow's Protagenic Therapeutics shares are currently valued at $169.52k.

If you're new to stock investing, here's how to buy Protagenic Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.